Literature DB >> 3106206

Granule enzymes of human and rabbit polymorphonuclear leukocytes: an investigation of enzyme solubility.

P D Brown, G B Robinson.   

Abstract

Granules were isolated from both human and rabbit polymorphonuclear leukocytes (PMNs), and the quantity and solubility of certain granule enzymes compared. Lysozyme and alpha-mannosidase were found to be the most soluble enzymes in the granules of both species and could be released by lysis with 0.1% (v/v) Triton X-100. Alkaline phosphatase was also released by this lytic procedure, but its release required higher concentrations of Triton. The main difference between the species was found in the less-soluble enzymes that were retained as an insoluble complex after lysis by Triton X-100. Both myeloperoxidase and the neutral proteinase activity of rabbit PMNs were found to be highly insoluble, requiring 0.6 M sodium chloride for their extraction from this complex. The corresponding enzymes from human PMNs were more soluble, 0.15 M sodium chloride releasing the majority of the neutral proteinase activity. In addition, the insolubility of the rabbit neutral proteinase activity seemed to prevent its release from PMNs stimulated to degranulate in vitro by treatment with the calcium ionophore, A23187. Since rabbit PMNs were also shown to contain significantly less neutral proteinase activity than human PMNs, it would seem that the rabbit is a poor model for the study of PMN-mediated tissue injury in man.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106206     DOI: 10.1007/bf00917775

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  30 in total

1.  Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1-protease inhibitor reactive site.

Authors:  K Nakajima; J C Powers; B M Ashe; M Zimmerman
Journal:  J Biol Chem       Date:  1979-05-25       Impact factor: 5.157

2.  A new method for the isolation of renal basement membranes.

Authors:  F S Ligler; G B Robinson
Journal:  Biochim Biophys Acta       Date:  1977-08-01

3.  Characterization of cationic protein-bearing granules of polymorphonuclear leukocytes.

Authors:  H I Zeya; J K Spitznagel
Journal:  Lab Invest       Date:  1971-03       Impact factor: 5.662

4.  The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles.

Authors:  P M Henson
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Subcellular distribution of neutral protease and peptidases in rabbit polymorphonuclear leucocytes.

Authors:  P Davies; K Krakauer; G Weissmann
Journal:  Nature       Date:  1970-11-21       Impact factor: 49.962

7.  A kinetic study of the degradation of human glomerular basement membrane by human polymorphonuclear leucocyte azurophil granules: supportive evidence for the involvement of leucocytes in glomerulonephritis [proceedings].

Authors:  K T Hughes; M Davies; E Sanders; G A Coles
Journal:  Biochem Soc Trans       Date:  1979-10       Impact factor: 5.407

8.  Degradation of rat or sheep glomerular basement membrane by rabbit neutrophils in vitro. The roles of proteinases, complement and oxygen-derived radicals.

Authors:  J Bray; D A Hume; G B Robinson
Journal:  Mol Biol Med       Date:  1983-09

9.  Characterization of a neutral protease from lysosomes of rabbit polymorphonuclear leucocytes.

Authors:  P Davies; G A Rita; K Krakauer; G Weissmann
Journal:  Biochem J       Date:  1971-07       Impact factor: 3.857

10.  Subcellular localization and heterogeneity of neutral proteases in neutrophilic polymorphonuclear leukocytes.

Authors:  B Dewald; R Rindler-Ludwig; U Bretz; M Baggiolini
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.